OverviewChartTechnicalNewsTraderScreen

DBV Technologies SA/  FR0010417345  /

Euronext - Paris
18/06/2024  17:35:05 Chg. +0.021 Volume Bid17:40:00 Ask17:40:00 High Low
0.974EUR +2.20% 38,447
Turnover: 37,312.928		 0.958Bid Size: 270 0.984Ask Size: 1,650 0.986 0.953
GlobeNewswire 05/06 DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire 04/06 Information regarding the total number of voting rights and total number of shares of the Company a...
GlobeNewswire 31/05 DBV Technologies Announces Plan to Implement ADS Ratio Change
GlobeNewswire 30/05 DBV Technologies to Participate in Upcoming EAACI 2024 Congress
GlobeNewswire 17/05 DBV Technologies Announces Plan to Implement ADS Ratio Change
GlobeNewswire 16/05 DBV Technologies Announces Results of its 2024 Combined General Meeting
GlobeNewswire 09/05 DBV Technologies to Participate in Upcoming Investor Conferences
GlobeNewswire 07/05 DBV Technologies Reports First Quarter 2024 Financial Results and Business Update
GlobeNewswire 25/04 Combined General Meeting of May 16, 2024
GlobeNewswire 04/04 Information regarding the total number of voting rights and total number of shares of the Company a...
GlobeNewswire 01/04 Autolus Therapeutics Announces Changes to its Board of Directors
GlobeNewswire 08/03 DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Docu...
GlobeNewswire 07/03 DBV Technologies Reports Full Year 2023 Financial Results and Business Update
GlobeNewswire 04/03 DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024
GlobeNewswire 20/02 DBV Technologies to Participate in Upcoming AAAAI 2024 Congress
GlobeNewswire 16/01 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
GlobeNewswire 04/12/2023 Information regarding the total number of voting rights and total number of shares of the Company a...
GlobeNewswire 09/11/2023 DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE T...
GlobeNewswire 06/11/2023 Monthly information regarding the total number of voting rights and total number of shares of the C...
GlobeNewswire 02/11/2023 DBV Technologies to Present New Data at ACAAI 2023
GlobeNewswire 31/10/2023 DBV Technologies Receives Requested Feedback from FDA on Protocol Design Elements for COMFORT Safety...
GlobeNewswire 27/10/2023 DBV Technologies to Report Third Quarter 2023 Financial Results and Business Update
GlobeNewswire 16/10/2023 DBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial Officer
GlobeNewswire 05/10/2023 Monthly information regarding the total number of voting rights and total number of shares of the C...
GlobeNewswire 05/09/2023 DBV Technologies to Participate in Upcoming Investor Conference